Monitoring and Medical Supervision: While AOD-9604 has a favorable safety profile, medical supervision is recommended, particularly for individuals with pre-existing health conditions
These products are not regulated for product accuracy, safety, and labeling
However, AOD 9604 therapy is not recommended for: Pregnant or breastfeeding individuals People with cancer history (because of the need for safety clearance due to the growth aspect) Individuals with uncontrolled chronic disease unless cleared by physician Always speak to your licensed healthcare provider before proceeding with peptide therapy to determine if its a fit for your health status and goals
Fatigue : While B12 typically boosts energy, some people might initially experience fatigue as their body adjusts to the treatment
Injections enter the body more directly
Furthermore, this trend toward increased alpha diversity in the obese groups placed on an LD that had consequently experienced weight loss aligns with clinical observations, where low gene richness has been associated with increased adiposity, insulin resistance, and dyslipidemia 70 while increased gene richness has been observed following dietary intervention in obese and overweight individuals 71
